Invesco’s Oramed Pharmaceuticals ORMP Stock Holding History

Invesco’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$119K	Buy	+24,751	New	+$98.5K	﹤0.01%	3711
2023 Q4	–	Sell	-10,094	Closed	-$26.3K	–	3880
2023 Q3	$26.3K	Buy	+10,094	New	+$31.8K	﹤0.01%	3847
2023 Q2	–	Sell	-13,375	Closed	-$29.2K	–	3918
2023 Q1	$29.2K	Buy	+13,375	New	+$42.5K	﹤0.01%	3790
2022 Q2	–	Sell	-14,370	Closed	-$124K	–	4113
2022 Q1	$124K	Buy	14,370 +1,379	+11%	+$14.1K	﹤0.01%	3849
2021 Q4	$186K	Sell	12,991 -742,204	-98%	-$15.5M	﹤0.01%	3800
2021 Q3	$16.6M	Buy	755,195 +743,715	+6,478%	+$12.7M	﹤0.01%	1683
2021 Q2	$154K	Buy	+11,480	New	+$131K	﹤0.01%	3833

Other funds holding ORMP

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco's ORMP Position: Q2 2026 in Review

Invesco opened a new position in Oramed Pharmaceuticals (ORMP) in Q2 2026: 24,751 shares worth $119K. The stake represents ﹤0.01% of the portfolio and ranks #3711 among its holdings. This is a return to the name: Invesco previously reported a position in ORMP as recently as Q3 2023.

Invesco first reported a position in ORMP in Q2 2021 and has held it in 7 quarters since. The position peaked at $16.6M in Q3 2021. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

Invesco held 24,751 shares of Oramed Pharmaceuticals worth $119K as of Q2 2026.
Oramed Pharmaceuticals was a new Invesco position in Q2 2026.
Oramed Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3711 holding.
Invesco first reported a position in Oramed Pharmaceuticals in Q2 2021 and has held it in 7 quarters since.
Invesco's Oramed Pharmaceuticals position peaked at $16.6M in Q3 2021.
84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.